March 14, 2005 NASD OTC-BB: MRDAF

Meridian Receives FDA Approval for the Lapex-2000
A Low-Level Laser Therapy Device

Meridian Co., Ltd. ("Meridian" or the “Company”) (OTC BB: MRDAF), is very pleased to receive FDA approval for its low-level laser therapy device, the Lapex-2000.

More About: Lapex-2000

The Lapex-2000 uses low-level laser therapy (“LLLT”), which delivers a laser light to various areas of the body without damaging the skin tissue. The light source is placed in contact with the skin allowing the photon energy to penetrate tissue. The body then coverts the photon energy into biochemical energy by interacting with cellular structures resulting in the restoration of normal cell function and enhancement of the body's natural healing process. The Lapex-2000 is digitally controlled with an LCD screen and is easy to operate.

The Lapex-2000 is approved for use in treating Carpal Tunnel Syndrome (“CTS”). LLLT has been used to effectively treat a variety of conditions including rheumatoid arthritis, immune system disorders, sports injuries, inflammations, Angina Pectoris, Cerebral infarction, fibroid tissue and functional disorders in muscles, tendons and joints, as well as increasing and improving blood supply. The Company believes its product can greatly reduce the need for medication and surgery while helping people towards a more active and less painful lifestyle.

To learn more about the Company’s product line view Meridian’s Interview with the Chicago Stock Exchange – ItsAboutFinance.com – by clicking the link below:

http://media4.streamtoyou.com/MRDAFDesc.wmv

More About: Low-Level Laser Therapy

Several conditions involving pain can be treated effectively with LLLT, therefore the Company is anticipating that the Lapex-2000 will by a major revenue source for 2005. There are a large number of pain management specialists that would benefit from the use of Meridian’s high quality low-level laser therapy device, such as Physiotherapists, Sports Medicine professionals, sports team coaches and trainers, Chiropractors, Masseurs, and general practitioners.

More than 30 million people visited chiropractic doctors last year for a variety of conditions, and more and more medical doctors are referring their patients to chiropractic doctors. It is estimated that in 2010 there will be over 100,000 chiropractors in the United States, the 3rd largest doctoral-level health care profession after medicine and dentistry.

LLLT is one of today’s most effective healing tools. Unlike many therapies and drugs that just treat symptoms, LLLT has the ability to actually promote and enhance healing. LLLT is the future of medicine and is a modality that is rapidly growing in popularity throughout the world.
LLLT’s Long Term Cumulative Effects
• ATP production is increased by increasing the number and productivity of mitochondria resulting in improved cellular metabolism;
• Increased levels of serotonin production and endorphins (the body’s natural mood-enhancing and pain relief hormones);
• Regulates electrolyte balance
• Stimulates immune response
• Reduces inflammation by suppressing inflammatory enzymes that create swelling, redness, pain, and heat and enhance the release of anti-inflammatory enzymes;
• Enhances lymphatic drainage, which increases circulation, reduces edema and speeds healing.
• Stimulates the healing process
• Release and production of growth hormone

More About: Meridian

Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.

For further information please contact:
Optima Capital
(403) 547-1576

Or Belgium Medical Inc.
1-877-738-8119